Ted Myles Appointed CEO of Cellarity

Ted Myles has been appointed as the new Chief Executive Officer of Cellarity, a life sciences company, and will also serve as CEO-Partner at Flagship Pioneering, according to a press release.

Cellarity, a life sciences company, has announced the appointment of Ted Myles as its new Chief Executive Officer. Myles will also join Flagship Pioneering as a CEO-Partner, announced in a press release.

Myles brings extensive experience in the biopharma industry, having previously served as Chief Financial Officer and Chief Operating Officer at Scholar Rock. During his tenure, he led the company through significant growth phases, including a successful Phase 3 study and raising over $1 billion in capital. His past roles also include leadership positions at AMAG Pharmaceuticals, Ocata Therapeutics, and PrimeraDx.

Cellarity is advancing its AI/ML-enabled platform to uncover novel druggable biology for complex diseases. The company's lead program, CLY-124, is a potential first-in-class small molecule for sickle cell disease, expected to enter clinical development in mid-2025. Myles' leadership is anticipated to be pivotal as Cellarity approaches its first clinical study this year.

We hope you enjoyed this article.

Consider subscribing to one of several newsletters we publish. For example, in the Daily AI Brief you can read the most up to date AI news round-up 6 days per week.

Also, consider following us on social media:

Subscribe to Daily AI Brief

Daily report covering major AI developments and industry news, with both top stories and complete market updates

Sponsored

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more